Log In
Print
BCIQ
Print
Print this Print this
 

FX06MRI

  Manage Alerts
Collapse Summary General Information
Company Fibrex Medical Inc.
DescriptionAnti-inflammatory peptide that inhibits the binding of fibrin E1 fragment to vascular endothelial (VE) cadherin
Molecular Target Fibrin
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationIschemia / reperfusion injury
Indication DetailsPrevent ischemia/reperfusion injury following revascularization for acute myocardial infarction (AMI); Treat ischemia/reperfusion injury after revascularisation therapy for myocardial infarction (MI)
Regulatory Designation

Partner

Ikaria Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today